File:Ampligen Exercise Tolerance-graph1.png

Figure 1: Robustness of dichotomized patient responses from ≥ 25% to ≤ 50% ET improvement at 5% increments; Panel A. ITT population. Panel B. protocol pre-declared ITT population subset with baseline ET duration >9 minutes.

Citation: Strayer DR, Stouch BC, Stevens SR, Bateman L, Lapp CW, et al. (2015) Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME): Characteristics of Responders to Rintatolimod. J Drug Res Dev 1(1): doi http://doi.org/10.16966/2470-1009.103

https://pdfs.semanticscholar.org/3129/b6edd819eedac0c1b966f38f146d35e08205.pdf